title: Enhancement of eosinophil-mediated cytotoxicity to schistosomula of Schistosoma mansoni by autologous mononuclear cells from patients.
abstract: Adherent mononuclear cells (monolayer), when co-cultured with autologous peripheral blood eosinophils isolated from patients treated for Schistosoma mansoni infections, enhanced the eosinophil-mediated killing of antibody coated schistosomula. The monolayer increased the activity of the eosinophils by 225%, and was observed in 80% of the patients studied. Heat labile factors other than complement, present in immune serum, further enhanced the ability of eosinophils to kill schistosomula in the presence of the monolayer. On their own the adherent cells did not mediate obvious damage to the parasite. Eosinophils that had been pre-incubated with the monolayer (100 mins) and tested separately, killed equal numbers of schistosomula as in the co-culture assay; this excludes the possibility of concurrent schistosomula cytotoxicity by the two cell populations. The ability of the monolayer to activate eosinophils was not altered by inhibitors of protein synthesis. The monolayer was largely consistent of monocytes as demonstrated by an over 96% positive staining for non-specific esterases.
authors.affiliation: Biomedical Sciences Research Centre, Kenya Medical Research Institute, Nairobi.
authors.forename: G
authors.initials: G
authors.lastname: Kimani
authors.forename: G M
authors.initials: GM
authors.lastname: Mkoji
authors.forename: J R
authors.initials: JR
authors.lastname: Rashid
authors.forename: J M
authors.initials: JM
authors.lastname: Mbugua
authors.forename: D
authors.initials: D
authors.lastname: Koech
authors.forename: T
authors.initials: T
authors.lastname: Kamau
authors.forename: B
authors.initials: B
authors.lastname: Mungai
mesh_terms: D000818:Animals; D000909:Antibodies, Helminth / Q000276:immunology; D000947:Antigens, Helminth / Q000276:immunology; D002478:Cells, Cultured; D003165:Complement System Proteins / Q000276:immunology; D003602:Cytotoxicity, Immunologic / Q000276:immunology*; D004804:Eosinophils / Q000276:immunology*; D006801:Humans; D007958:Leukocyte Count; D009000:Monocytes / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology*; D011223:Praziquantel / Q000627:therapeutic use; D011500:Protein Synthesis Inhibitors / Q000276:immunology; D012550:Schistosoma mansoni / Q000276:immunology*; D012555:Schistosomiasis mansoni / Q000188:drug therapy / Q000276:immunology*
chemical_list: D000909:Antibodies, Helminth; D000947:Antigens, Helminth; D011500:Protein Synthesis Inhibitors; D011223:Praziquantel; D003165:Complement System Proteins